Grifols S.A. Logo

Grifols S.A.

Leading producer of plasma-derived medicines for patients with rare and chronic diseases.

GRF | MC

Overview

Corporate Details

ISIN(s):
ES0171996087 (+4 more)
LEI:
959800HSSNXWRKBK4N60
Country:
Spain
Address:
Avenida de la Generalitat 152-158, 08174 Sant Cugat del Vallès
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Grifols is a global healthcare company and a leading producer of plasma-derived medicines. Founded in 1909, the company develops, produces, and markets innovative biopharmaceuticals and solutions in transfusion medicine to improve the health and well-being of people worldwide. Its core activities are centered on its expertise in plasma science, serving patients with chronic and rare diseases across various therapeutic areas, including immunology, neurology, and critical care. Grifols provides a range of products and services through its primary divisions: Bioscience, Diagnostic, and Hospital. The company is committed to the highest standards of safety and quality, leveraging scientific innovation to treat diseases and enhance patient lives.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-12 00:00
Director's Dealing
Motivo de la notificación: Persona con Responsabilidad de Dirección
Spanish 91.4 KB
2025-06-13 00:00
Director's Dealing
Motivo de la notificación: Persona Estrechamente Vinculada
Spanish 91.4 KB
2025-06-06 00:00
Director's Dealing
Motivo de la notificación: Persona con Responsabilidad de Dirección
Spanish 91.4 KB
2025-05-19 00:00
Director's Dealing
Motivo de la notificación: Persona con Responsabilidad de Dirección
Spanish 91.4 KB
2025-05-16 00:00
Director's Dealing
Motivo de la notificación: Persona con Responsabilidad de Dirección
Spanish 91.4 KB
2025-05-12 17:36
Earnings Release
Grifols anuncia la información financiera del primer trimestre de 2025
Spanish 1.3 MB
2025-05-06 12:54
M&A Activity
Como continuación de la Información Privilegiada presentada por Grifols el 31 d…
Spanish 43.3 KB
2025-05-02 08:04
Pre-Annual General Meeting Information
Convocatoria de la Junta General Ordinaria de Accionistas 2025 de Grifols, S.A.
Spanish 137.8 KB
2025-05-02 00:00
Pre-Annual General Meeting Information
Convocatoria de la Junta General Ordinaria de Accionistas 2025 de Grifols, S.A.
Spanish 137.8 KB
2025-04-02 13:40
M&A Activity
Brookfield Capital Partners realiza comunicación en relación a noticias de pren…
Spanish 86.2 KB
2025-04-02 11:30
Regulatory News Service
Con respecto a la información publicada en ciertos medios de comunicación.
Spanish 39.1 KB
2025-03-31 08:57
Delisting Announcement
El Consejo de Administración ha aprobado por unanimidad que su filial Grifols B…
Spanish 41.6 KB
2025-03-14 00:00
Director's Dealing
Motivo de la notificación: Persona con Responsabilidad de Dirección
Spanish 91.4 KB
2025-03-10 12:55
Legal Proceedings Report
Grifols desea informar sobre cierta información publicada en un medio de comuni…
Spanish 54.6 KB
2025-03-05 00:00
Director's Dealing
Motivo de la notificación: Persona con Responsabilidad de Dirección
Spanish 94.7 KB

Automate Your Workflow. Get a real-time feed of all Grifols S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Grifols S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Biovica International B Logo
Develops blood tests to monitor the efficacy of solid tumor cancer therapies.
Sweden BIOVIC
BL Pharmtech Corp. Logo
Manufactures and distributes health foods, supplements, and cosmetics with bio-pharmaceutical R&D.
South Korea 065170
BOIRON Logo
Global manufacturer of homeopathic medicines for pain relief and flu-like symptoms, sold worldwide.
France BOI
Bosnalijek d.d. Sarajevo Logo
Global manufacturer of drugs for digestive, metabolic, and cardiovascular health.
Bosnia and Herzegovina BSNL
R&D pharma firm developing drugs for CNS disorders, oncology, and metabolic diseases.
South Korea 003000
Calliditas Therapeutics Logo
Develops and commercializes novel treatments for rare renal and hepatic diseases like IgA nephropathy.
Sweden CALTX
CALTH. Inc Logo
Develops AI-powered rapid diagnostic solutions for point-of-care and self-testing.
South Korea 402420
CAMBRIDGE NUTRITIONAL SCIENCES PLC Logo
Develops and manufactures diagnostic tests for food sensitivity and gut health.
United Kingdom CNSL
Camurus Logo
Develops long-acting medicines for severe chronic diseases using advanced drug delivery.
Sweden CAMX
Clinical-stage biopharma developing novel cancer drugs aiming for fewer side effects.
Japan 4575

Talk to a Data Expert

Have a question? We'll get back to you promptly.